# Early Treatment of Recurrent HCV- Infection Post Liver Transplantation in the Era of DAAs

> **NCT03133065** · PHASE4 · COMPLETED · sponsor: **Ain Shams University** · enrollment: 89 (actual)

## Conditions studied

- Liver Transplantation

## Interventions

- **DRUG:** treatment of HCV with oral direct acting antiviral therapy

## Key facts

- **NCT ID:** NCT03133065
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-09
- **Primary completion:** 2016-12
- **Final completion:** 2017-04
- **Target enrollment:** 89 (ACTUAL)
- **Last updated:** 2017-04-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03133065

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03133065, "Early Treatment of Recurrent HCV- Infection Post Liver Transplantation in the Era of DAAs". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03133065. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*